Core Viewpoint - JD.com, Inc. is expected to show strong earnings growth in its upcoming report, with significant increases in both EPS and revenue compared to the previous year [2][3]. Company Performance - JD.com, Inc. closed at $42.24, reflecting a -1.72% change from the previous day's closing price, which is less than the S&P 500's daily gain of 0.08% [1] - Over the past month, JD.com shares have gained 4.35%, while the Retail-Wholesale sector and the S&P 500 have lost 9.1% and 7.33%, respectively [1]. Earnings Estimates - The upcoming earnings report is anticipated to show an EPS of $1.08, representing a 38.46% increase year-over-year, with revenue expected to reach $40.07 billion, indicating an 11.27% increase [2]. - For the entire year, earnings are forecasted at $4.58 per share and revenue at $173.05 billion, reflecting increases of +7.51% and +7.65% compared to the previous year [3]. Analyst Sentiment - Recent modifications to analyst estimates for JD.com indicate positive sentiment regarding the company's business operations and profit generation capabilities [4]. - The Zacks Rank system currently rates JD.com as 1 (Strong Buy), with a historical average annual return of +25% for stocks rated 1 since 1988 [6]. Valuation Metrics - JD.com is trading at a Forward P/E ratio of 9.39, which is a discount compared to the industry average of 21.86 [7]. - The company has a PEG ratio of 0.29, significantly lower than the Internet - Commerce industry's average PEG ratio of 1.16 [7]. Industry Context - The Internet - Commerce industry, part of the Retail-Wholesale sector, holds a Zacks Industry Rank of 72, placing it in the top 29% of over 250 industries [8].

Core Insights - Southern Copper (SCCO) stock closed at $100.41, reflecting a +1.2% increase, outperforming the S&P 500's gain of 0.08% [1] - Over the past month, SCCO shares increased by 1.43%, while the Basic Materials sector and S&P 500 saw declines of 1.45% and 7.33%, respectively [1] Earnings Performance - Southern Copper is expected to report earnings of $1.05 per share, indicating a year-over-year growth of 11.7% [2] - Revenue is projected at $2.79 billion, representing a 7.48% increase from the same quarter last year [2] - For the fiscal year, earnings are estimated at $4.65 per share and revenue at $11.7 billion, reflecting changes of +7.39% and +2.31% from the prior year [3] Analyst Estimates - Changes in analyst estimates for Southern Copper are crucial as they reflect short-term business trends [4] - Positive revisions in estimates indicate analyst optimism regarding the company's business and profitability [4] Zacks Rank and Stock Performance - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), shows Southern Copper currently holds a rank of 3 (Hold) [6] - The consensus EPS projection has increased by 1.79% in the past 30 days [6] Valuation Metrics - Southern Copper has a Forward P/E ratio of 21.32, which is higher than the industry average of 18.96 [7] - The company has a PEG ratio of 1.93, compared to the Mining - Non Ferrous industry's average PEG ratio of 0.89 [7] Industry Context - The Mining - Non Ferrous industry is part of the Basic Materials sector and currently holds a Zacks Industry Rank of 202, placing it in the bottom 20% of over 250 industries [8] - Stronger industry groups, as measured by the Zacks Industry Rank, tend to outperform weaker groups by a factor of 2 to 1 [8]

Company Performance - Walmart's stock closed at $85.90, reflecting a +0.1% change from the previous day, outperforming the S&P 500's gain of 0.08% [1] - Over the past month, Walmart's shares have decreased by 11.73%, underperforming the Retail-Wholesale sector's loss of 9.1% and the S&P 500's loss of 7.33% [1] Upcoming Earnings - Analysts expect Walmart to report an EPS of $0.59, which is a 1.67% decline compared to the same quarter last year [2] - Revenue is anticipated to be $165.92 billion, indicating a 2.73% increase year-over-year [2] Fiscal Year Estimates - For the entire fiscal year, earnings are projected at $2.63 per share and revenue at $703.77 billion, reflecting increases of +4.78% and +3.35% respectively from the previous year [3] - Recent changes in analyst estimates suggest a positive outlook for Walmart's business and profitability [3] Analyst Ratings - The Zacks Rank system currently rates Walmart as 3 (Hold), with a 4.09% decline in the Zacks Consensus EPS estimate over the past month [5] - The Zacks Rank has a historical track record of outperformance, with 1 stocks averaging a +25% annual return since 1988 [5] Valuation Metrics - Walmart's Forward P/E ratio stands at 32.66, which is a premium compared to the industry's Forward P/E of 13.06 [6] - The PEG ratio for Walmart is 4.56, while the average PEG ratio for the Retail - Supermarkets industry is 2.1 [6] Industry Context - The Retail - Supermarkets industry is part of the Retail-Wholesale sector and holds a Zacks Industry Rank of 82, placing it in the top 33% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Company Performance - Gilead Sciences (GILD) closed at $105.87, down 1.53% from the previous trading day, underperforming the S&P 500's loss of 0.22% [1] - Over the past month, Gilead's shares have decreased by 0.13%, which is better than the Medical sector's loss of 0.63% and the S&P 500's loss of 7.48% [1] Earnings Forecast - Gilead is expected to report an EPS of $1.73, representing a significant growth of 231.06% compared to the same quarter last year [2] - The Zacks Consensus Estimate for revenue is projected at $6.78 billion, reflecting a 1.36% increase from the previous year [2] Annual Estimates - For the entire year, earnings are forecasted at $7.87 per share, indicating a growth of 70.35%, while revenue is expected to be $28.55 billion, showing a slight decline of 0.7% compared to the previous year [3] - Recent analyst estimate revisions suggest a positive outlook for Gilead's business and profitability [3] Valuation Metrics - Gilead Sciences has a Forward P/E ratio of 13.67, which is lower than the industry's average Forward P/E of 19.05 [6] - The company has a PEG ratio of 0.7, compared to the industry average PEG ratio of 1.56, indicating a favorable valuation relative to projected earnings growth [6] Industry Context - The Medical - Biomedical and Genetics industry, which includes Gilead, has a Zacks Industry Rank of 75, placing it in the top 30% of over 250 industries [7] - Research indicates that higher-ranked industries tend to outperform lower-ranked ones by a factor of 2 to 1 [7]

Company Performance - Progressive (PGR) stock closed at $274.62, with a +0.49% change compared to the previous day, outperforming the S&P 500's loss of 0.22% [1] - Over the past month, shares of Progressive gained 1.36%, while the Finance sector lost 3.33% and the S&P 500 lost 7.48% [1] Upcoming Financial Results - The upcoming EPS for Progressive is projected at $4.35, indicating a 16.62% increase year-over-year [2] - Revenue is anticipated to be $20.52 billion, reflecting a 20.07% increase from the same quarter last year [2] Full Year Estimates - For the full year, earnings are projected at $15.19 per share and revenue at $87.44 billion, showing increases of +8.11% and +16.42% respectively from the previous year [3] Analyst Estimates - Recent changes to analyst estimates for Progressive suggest a favorable outlook on the company's business health and profitability [4] Zacks Rank and Performance - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), currently ranks Progressive as 1 (Strong Buy), with a 5.33% rise in the Zacks Consensus EPS estimate over the past month [6] - Historically, 1 ranked stocks have contributed an average annual return of +25% since 1988 [6] Valuation Metrics - Progressive has a Forward P/E ratio of 17.99, which is higher than the industry average of 11.88, indicating it is trading at a premium [7] - The PEG ratio for Progressive is 1.65, compared to the industry average of 1.67 [8] Industry Context - The Insurance - Property and Casualty industry, part of the Finance sector, has a Zacks Industry Rank of 35, placing it in the top 14% of over 250 industries [9]

Core Insights - General Motors (GM) shares closed at $49.44, reflecting a -0.7% change from the previous session, underperforming the S&P 500's loss of 0.22% [1] - Over the last month, GM's shares increased by 4.16%, contrasting with the Auto-Tires-Trucks sector's decline of 20.08% and the S&P 500's decline of 7.48% [1] Earnings Projections - GM's upcoming earnings release is anticipated, with projected earnings per share (EPS) of $2.67, indicating a 1.91% increase year-over-year [2] - Revenue is estimated at $42.7 billion, reflecting a 0.73% decrease compared to the same quarter last year [2] - For the annual period, earnings are expected to be $11.52 per share and revenue at $180.2 billion, representing shifts of +8.68% and -3.87% respectively from the previous year [3] Analyst Estimates - Recent changes in analyst estimates for GM suggest positive sentiment regarding the company's business operations and profit generation capabilities [4] - The Zacks Rank system, which incorporates these estimate changes, currently ranks GM as 2 (Buy) [6] Valuation Metrics - GM has a Forward P/E ratio of 4.32, indicating a discount compared to its industry's Forward P/E of 11.13 [7] - The company also has a PEG ratio of 0.69, which is lower than the Automotive - Domestic industry's average PEG ratio of 0.82 [7] Industry Context - The Automotive - Domestic industry is part of the Auto-Tires-Trucks sector, holding a Zacks Industry Rank of 132, placing it in the bottom 48% of over 250 industries [8] - Research indicates that top-rated industries outperform the bottom half by a factor of 2 to 1 [8]

The latest trading session saw Lululemon (LULU) ending at $324.45, denoting a -1.55% adjustment from its last day's close. This change lagged the S&P 500's daily loss of 0.22%. Elsewhere, the Dow lost 0.03%, while the tech-heavy Nasdaq lost 0.33%.Shares of the athletic apparel maker have depreciated by 10.25% over the course of the past month, underperforming the Consumer Discretionary sector's loss of 8.76% and the S&P 500's loss of 7.48%.The investment community will be paying close attention to the earni ...

Core Viewpoint - Guild Holdings Company (GHLD) is currently viewed as a better value investment compared to HA Sustainable Infrastructure Capital (HASI) based on earnings outlook and valuation metrics [3][7]. Valuation Metrics - GHLD has a forward P/E ratio of 8.04, while HASI has a forward P/E of 11.10 [5]. - GHLD's PEG ratio is 0.26, indicating a favorable growth outlook compared to HASI's PEG ratio of 0.99 [5]. - GHLD's P/B ratio stands at 0.66, significantly lower than HASI's P/B of 1.45, suggesting GHLD is undervalued relative to its book value [6]. Earnings Outlook - GHLD has shown a stronger improvement in its earnings outlook compared to HASI, contributing to its higher Zacks Rank of 2 (Buy) versus HASI's 3 (Hold) [3][7]. Value Grades - GHLD has a Value grade of B, while HASI has a Value grade of D, reflecting GHLD's superior valuation metrics [6].

Core Insights - The article compares The Charles Schwab Corporation (SCHW) and MarketAxess (MKTX) to identify which stock presents a better value opportunity for investors [1] Valuation Metrics - SCHW has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while MKTX has a Zacks Rank of 3 (Hold) [3] - SCHW's forward P/E ratio is 18.66, significantly lower than MKTX's forward P/E of 28.15 [5] - SCHW has a PEG ratio of 0.97, while MKTX's PEG ratio is much higher at 4.99, suggesting SCHW is more reasonably priced relative to its expected earnings growth [5] - SCHW's P/B ratio stands at 3.58, compared to MKTX's P/B of 5.89, further indicating that SCHW is undervalued [6] - Based on these metrics, SCHW holds a Value grade of B, whereas MKTX has a Value grade of F, highlighting SCHW's superior valuation [6] Conclusion - Given the stronger estimate revision activity and more attractive valuation metrics, SCHW is positioned as the superior option for value investors at this time [7]

Core Viewpoint - Eli Lilly is positioned as a leading growth stock in the healthcare sector, driven by a strong pipeline of innovative drugs, significant investments in manufacturing, robust financial performance, a growing dividend, and an attractive valuation based on its PEG ratio [1][2][15]. Group 1: Drug Pipeline and Growth Opportunities - Eli Lilly has a strong pipeline of drugs, particularly in the GLP-1 category, with approved drugs like Zepbound and Mounjaro expected to generate substantial revenue [3][4]. - The company is also optimistic about its Alzheimer's drug Kisunla and has entered into an agreement with Aktis Oncology to develop targeted cancer treatments, showcasing its commitment to innovation [4][5]. Group 2: Manufacturing Investments - To meet the growing demand for its GLP-1 drugs, Eli Lilly is investing heavily in U.S. manufacturing, with plans to invest $27 billion in four new manufacturing locations [6][7]. - Over the past five years, the company has announced more than $50 billion in manufacturing investments, marking it as the largest pharmaceutical expansion investment in U.S. history [7]. Group 3: Financial Performance - Eli Lilly's revenue increased by 32% to over $45 billion last year, with net income doubling to $10.6 billion and cash flow from operations reaching $8.8 billion [9][10]. - The company has demonstrated strong financials, allowing it to reinvest in its operations and pipeline for future growth [10]. Group 4: Dividend Growth - Eli Lilly has a growing dividend, with a recent 15% increase announced in December, marking the seventh consecutive year of significant dividend boosts [11][12]. - The company's dividend growth is expected to continue, providing long-term investors with a valuable income stream [12]. Group 5: Valuation Metrics - Despite trading at close to 70 times its trailing earnings, Eli Lilly's PEG ratio of 1.2 suggests that the stock remains a solid buy when considering expected growth [13][14]. - The modest PEG ratio indicates that the stock is not as expensive as it may initially appear, making it an attractive investment opportunity [14].